OPKO HEALTH, INC. — Institutional Ownership
Which tracked institutions hold OPK, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
24
Funds holding
$105229894
Total value held
Buying
17 added/new · 5 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $55468342 | 36978893 | +746670 | +2.06% |
| 2 | State Street Corp | $15463605 | 10309070 | +807693 | +8.50% |
| 3 | Goldman Sachs Group Inc | $10553239 | 7035492 | -639534 | -8.33% |
| 4 | Ubs Group Ag | $7509427 | 5006284 | +5006284 | NEW BUY |
| 5 | Northern Trust Corp | $5634246 | 3756163 | +136817 | +3.78% |
| 6 | Morgan Stanley | $2962542 | 1975027 | +778940 | +65.12% |
| 7 | Bank Of New York Mellon Corp | $1994961 | 1329974 | +49932 | +3.90% |
| 8 | Bank Of America Corp /De/ | $1193573 | 795716 | -346133 | -30.31% |
| 9 | Jpmorgan Chase & Co | $1126985 | 862305 | -380179 | -30.60% |
| 10 | Invesco Ltd. | $1027615 | 685076 | +685076 | NEW BUY |
| 11 | Wells Fargo & Company/Mn | $531059 | 354039 | +191430 | +117.72% |
| 12 | Royal Bank Of Canada | $435000 | 289812 | +69818 | +31.74% |
| 13 | Citigroup Inc | $299737 | 199824 | +183282 | +1107.98% |
| 14 | Fifth Third Bancorp | $255000 | 170000 | +41209 | +32.00% |
| 15 | Janus Henderson Group Plc | $236230 | 206314 | +206314 | NEW BUY |
| 16 | Barclays Plc | $149395 | 99596 | -38704 | -27.99% |
| 17 | Ameriprise Financial Inc | $141092 | 94061 | +94061 | NEW BUY |
| 18 | Prudential Financial Inc | $103464 | 68976 | +3420 | +5.22% |
| 19 | Pnc Financial Services Group, Inc. | $55500 | 37000 | — | Held |
| 20 | Arrow Financial Corp | $38250 | 25500 | +500 | +2.00% |
| 21 | Raymond James Financial Inc | $32869 | 21912 | -10712 | -32.83% |
| 22 | Sei Investments Co | $15245 | 10163 | — | Held |
| 23 | Us Bancorp \De\ | $2352 | 1568 | +1568 | NEW BUY |
| 24 | Amalgamated Financial Corp. | $166 | 48211 | +48211 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.